IRCM - Institut de Recherche en Cancérologie de Montpellier
Laura Eanes Da Silva is currently a Doctorante en oncologie at IRCM - Institut de Recherche en Cancérologie de Montpellier, focusing on the identification of new treatments overcoming resistance to Cabozantinib in kidney cancer. Prior to this, Laura worked as a Stagiaire in Drug Discovery at AB Science and as a Stagiaire in fundamental research at Institut Jacques Monod. Laura also has experience as a medical secretary at Institut Robert Merle d'Aubigné. Laura holds a master's degree in Molecular Bases of Oncogenesis from Sorbonne Université, along with other degrees in biology and genetics.
IRCM - Institut de Recherche en Cancérologie de Montpellier
The Cancer Research Institute of Montpellier U1194 jointly operated by Inserm, University of Montpellier and Institut du Cancer de Montpellier (CLCC) 220 scientists and support personnel 17 research teams sharing 5000 m2 of lab space Excellent core facilities, many being part of the shared facilities network Montpellier BioCampus Biotech spin-offs Ground breaking research in basic and translational oncology developed in close collaboration with clinical departments and clinical research at ICM One central theme and two unifying programs : Molecular Targets and Cancer Therapy 1. Plasticity of solid tumors : from discoveries to personalized medecine 2. Therapeutic Antibodies in Cancer Treatment : Innovation, design and biological response